Inventor · disambiguated record
John H. Van Duzer
Also filed as: VAN DUZER JOHN · VAN DUZER JOHN H · VAN DUZER JOHN HENRY
55 granted patents·16 pending applications·924 citations·filing 1987–2023
99Inventor score
Files withACETYLON PHARMACEUTICALS INC19REGENACY PHARMACEUTICALS LLC12NOVARTIS AG9INOTEK PHARMACEUTICALS CORP6ACTIVBIOTICS INC4
Top patents by PatentIndex Score
71 records- 0198US9145412B2Selective HDAC1 and HDAC2 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2013·Granted Sep 29, 2015·30 cites·32 claims
- 0297US9421212B2Selective HDAC1 and HDAC2 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2015·Granted Aug 23, 2016·12 cites·9 claims
- 0396US9464073B2Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2015·Granted Oct 11, 2016·10 cites·12 claims
- 0496US9139583B2Selective HDAC3 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·20 cites·11 claims
- 0595US9096549B2Selective HDAC3 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Aug 4, 2015·26 cites·18 claims
- 0695US8614223B2Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereofVAN DUZER JOHN H·Filed 2011·Granted Dec 24, 2013·34 cites·16 claims
- 0795US8148526B1Reverse amide compounds as protein deacetylase inhibitors and methods of use thereofVAN DUZER JOHN H·Filed 2011·Granted Apr 3, 2012·38 cites·4 claims
- 0894US9790180B2Piperidine derivatives as HDAC1/2 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2015·Granted Oct 17, 2017·6 cites·7 claims
- 0994US8609678B2Reverse amide compounds as protein deacetylase inhibitors and methods of use thereofVAN DUZER JOHN H·Filed 2012·Granted Dec 17, 2013·30 cites·9 claims
- 1094US8394810B2Reverse amide compounds as protein deacetylase inhibitors and methods of use thereofVAN DUZER JOHN H·Filed 2011·Granted Mar 12, 2013·32 cites·4 claims
- 1194US6291523B1Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 1998·Granted Sep 18, 2001·117 cites·36 claims
- 1293US10239837B2Piperidine derivatives as HDAC1/2 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2017·Granted Mar 26, 2019·4 cites·5 claims
- 1393US9765066B2Selective HDAC1 and HDAC2 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Granted Sep 19, 2017·6 cites·14 claims
- 1493US6310099B1Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 2000·Granted Oct 30, 2001·54 cites·19 claims
- 1592US5260316AIsoquinolyl substituted hydroxylamine derivativesCIBA GEIGY CORP·Filed 1992·Granted Nov 9, 1993·72 cites·21 claims
- 1691US8524214B2Polyal drug conjugates comprising variable rate-releasing linkersYURKOVETSKIY ALEKSANDR·Filed 2010·Granted Sep 3, 2013·33 cites·30 claims
- 1791US6353017B1Dipeptide nitrilesNOVARTIS AG·Filed 2000·Granted Mar 5, 2002·52 cites·22 claims
- 1890US9562013B2Selective HDAC3 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2015·Granted Feb 7, 2017·7 cites·11 claims
- 1990US9278963B2Pyrimidine hydroxy amide compounds as histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Mar 8, 2016·17 cites·24 claims
- 2090US6828319B2Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2002·Granted Dec 7, 2004·34 cites·131 claims
- 2190US6174888B12-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-onesNOVARTIS AG·Filed 1998·Granted Jan 16, 2001·48 cites·9 claims
- 2290US5350761AIndolyl substituted hydroxylamine derivativesCIBA GEIGY CORP·Filed 1993·Granted Sep 27, 1994·54 cites·7 claims
- 2389US5334600AIsoquinolyl substituted hydroxylamine derivativesCIBA GEIGY CORP·Filed 1993·Granted Aug 2, 1994·50 cites·11 claims
- 2488US9409890B2Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2013·Granted Aug 9, 2016·9 cites·8 claims
- 2587US10358421B2Piperidine derivatives as HDAC1/2 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2017·Granted Jul 23, 2019·2 cites·17 claims
- 2687US9884850B2Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Granted Feb 6, 2018·2 cites·9 claims
- 2786US6956035B2Isoquinoline derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2003·Granted Oct 18, 2005·19 cites·22 claims
- 2884US6812237B2N-substituted peptidyl nitriles as cysteine cathepsin inhibitorsNOVARTIS AG·Filed 2001·Granted Nov 2, 2004·15 cites·16 claims
- 2984US6727281B2Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 2002·Granted Apr 27, 2004·13 cites·17 claims
- 3084US2023348389A1Piperidine derivatives as hdac1/2 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 3183US10144714B2Methods of making protein deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Granted Dec 4, 2018·3 cites·15 claims
- 3283US7547692B2Rifamycin analogs and uses thereofACTIVBIOTICS PHARMA LLC·Filed 2006·Granted Jun 16, 2009·10 cites·18 claims
- 3381US6451858B2Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 2001·Granted Sep 17, 2002·10 cites·10 claims
- 3479US10774056B2Substituted piperazines as selective HDAC1,2 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2019·Granted Sep 15, 2020·1 cites·4 claims
- 3578US7342011B2Rifamycin analogs and uses thereofACTIVBIOTICS INC·Filed 2004·Granted Mar 11, 2008·15 cites·12 claims
- 3678US7271165B2Rifamycin analogs and uses thereofACTIVBIOTICS INC·Filed 2004·Granted Sep 18, 2007·12 cites·6 claims
- 3775US11702389B2Piperidine derivatives as HDAC1/2 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2021·Granted Jul 18, 2023·0 cites·19 claims
- 3875US10370324B2Phenyl and pyridinyl hydroxamic acidsACETYLON PHARMACEUTICALS INC·Filed 2017·Granted Aug 6, 2019·1 cites·10 claims
- 3975US10125131B2Selective HDAC3 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2016·Granted Nov 13, 2018·1 cites·23 claims
- 4075US7115662B2Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 2003·Granted Oct 3, 2006·5 cites·18 claims
- 4174US7488726B2Rifamycin analogs and uses thereofACTIVBIOTICS PHARMA LLC·Filed 2006·Granted Feb 10, 2009·2 cites·17 claims
- 4273US10968180B2Piperidine derivatives as HDAC1/2 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2019·Granted Apr 6, 2021·0 cites·7 claims
- 4372US10927072B2Phenyl and pyridinyl hydroxamic acidsACETYLON PHARMACEUTICALS INC·Filed 2019·Granted Feb 23, 2021·0 cites·7 claims
- 4472US7078423B25-Aryltetrazole compounds, compositions thereof, and uses thereforINOTEK PHARMACEUTICALS CORP·Filed 2002·Granted Jul 18, 2006·6 cites·50 claims
- 4571US2022281833A1Substituted piperazines as selective hdac1,2 inhibitorsREGENACY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4670US11617750B2Reverse amide compounds as protein deacetylase inhibitors and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2019·Granted Apr 4, 2023·0 cites·13 claims
- 4770US7494991B2Rifamycin analogs and uses thereofACTIVBIOTICS PHARMA LLC·Filed 2007·Granted Feb 24, 2009·1 cites·21 claims
- 4868US10464906B2Crystalline forms of a histone deacetylase inhibitorACETYLON PHARMACEUTICALS INC·Filed 2016·Granted Nov 5, 2019·1 cites·4 claims
- 4968US7087631B2Aryltetrazole compounds, and compositions thereofINOTEK PHARMACEUTICALS CORP·Filed 2003·Granted Aug 8, 2006·3 cites·5 claims
- 5067US11542242B2Substituted piperazines as selective HDAC1,2 inhibitorsREGENACY PHARMACEUTICALS INC·Filed 2020·Granted Jan 3, 2023·0 cites·25 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →